Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Torres

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
The Oncologist|December 14, 2024
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO studyJavier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado, et al.
JAMA|February 10, 2022
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical TrialArturo Renú, Mónica Millán, Luis San Román, et al.
Hepatology (Baltimore, Md.)|February 22, 2023
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosisOana Nicoară-Farcău, Juan J Lozano, Cristina Alonso, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2023
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant dataCàndid Villanueva, Victor Sapena, Gin-Ho Lo, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 20, 2019
The Chemical Optimization of Cerebral Embolectomy trial: Study protocolArturo Renú, Jordi Blasco, Mónica Millán, et al.
Stroke and Vascular Neurology|December 3, 2025
Chemical Optimization of Cerebral Embolectomy 2 (CHOICE 2) trial: study protocolArturo Renú, Patricia de la Riva, Raquel Delgado-Mederos, et al.
Stem Cells International|March 15, 2018
A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study ProtocolEnrique Gómez-Barrena, Norma G Padilla-Eguiluz, Cristina Avendaño-Solá, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory MalignanciesValentín Ortíz-Maldonado, Susana Rives, Maria Castellà, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
The Oncologist|December 14, 2024
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO studyJavier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado, et al.
JAMA|February 10, 2022
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical TrialArturo Renú, Mónica Millán, Luis San Román, et al.
Hepatology (Baltimore, Md.)|February 22, 2023
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosisOana Nicoară-Farcău, Juan J Lozano, Cristina Alonso, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2023
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant dataCàndid Villanueva, Victor Sapena, Gin-Ho Lo, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 20, 2019
The Chemical Optimization of Cerebral Embolectomy trial: Study protocolArturo Renú, Jordi Blasco, Mónica Millán, et al.
Stroke and Vascular Neurology|December 3, 2025
Chemical Optimization of Cerebral Embolectomy 2 (CHOICE 2) trial: study protocolArturo Renú, Patricia de la Riva, Raquel Delgado-Mederos, et al.
Stem Cells International|March 15, 2018
A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study ProtocolEnrique Gómez-Barrena, Norma G Padilla-Eguiluz, Cristina Avendaño-Solá, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory MalignanciesValentín Ortíz-Maldonado, Susana Rives, Maria Castellà, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Pageof 18